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mutation. The sample was rerun and exhibited an identicalntroduction
o far, more  than 800 mutations involving the beta-globin gene
ave been characterized worldwide. Most of these variants are
lso carried by patients with Turkish origin, since Turkey is one
f the hotspot regions for mutations of the globin genes.1
In the present study, we report a case with an unusual
igh-performance liquid chromatography (HPLC) pattern who
urned out to be a carrier of the 78(EF2) Leu>Val; HBB: c.235
>G mutation. This mutation is previously unreported in Turk-
sh individuals.
ase  report
he patient attended our laboratory for hematological exams
ue to persistent anemia and hemoglobinopathy HPLC anal-
sis was ordered as hemoglobinopathies are common inPlease cite this article in press as: Hocaoglu-Emre FS, et al. First observa
Hemoter. 2016. http://dx.doi.org/10.1016/j.bjhh.2016.09.013
atients of Turkish descent.
The proband was a 70-year-old female from the eastern
lack Sea region.
∗ Corresponding author at: Duzen Laboratuvari, Mecidiyekoy Mah, Cem
E-mail address: sinememre@duzen.com.tr (F.S. Hocaoglu-Emre).
ttp://dx.doi.org/10.1016/j.bjhh.2016.09.013
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pen  access article under the CC BY-NC-ND license (http://creativecomThe complete blood count of the proband revealed a red
blood cell (RBC) count of 3.36 × 103/L, hemoglobin (Hb) level of
8.7 g/dL, mean corpuscular volume (MCV) of 81.1 fL and mean
corpuscular Hb (MCH) of 25.8 pg (Table 1).
HPLC analysis was performed using an in-house method
employing an ultra-speed HPLC system with a 415 nm UV/VIS-
Detector (Shimadzu Corp., Japan). The method to obtain a Hb
chromatogram was modiﬁed from Ou et al.2 The efﬁciency of
the system is controlled prior to every analysis using a ready-
to-use test solution containing the Hb variants Hb  A1c, Hb F, Hb
A, Hb E, Hb A2, Hb D, Hb S and Hb C, and control hemolysates at
two levels of concentration, each containing Hb F, Hb A, Hb A2
and Hb S (RECIPE Chemicals + Instruments GmbH, Germany).
In the HPLC analysis, the Hb A level was 38.8%, with a
slightly increased Hb A2 level (3.99%). No Hb F peak was seen
in the ﬁrst and following analyses. Besides this, an unknown
57.3% peak was identiﬁed in the Hb E window adjacent to the
Hb A peak, indicating a possible heterozygous hemoglobintion of Hb Ullevaal [78(EF2) Leu>Val] in Turkey. Rev Bras Hematol
al Sahir Sok, No: 14, Sisli, Istanbul, Turkey.
pattern (Figure 1).
In order to have a detailed analysis of the suspected muta-
tion, the beta globin gene was ampliﬁed by polymerase chain
 e Terapia Celular. Published by Elsevier Editora Ltda. This is an
mons.org/licenses/by-nc-nd/4.0/).
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Table 1 – The hematological and molecular data of the
patient.
Parameter Proband Reference range
Age (years) – gender 70, F –
Hb (g/dL) 8.7 13.0–17.0
RBC (×103/L) 3.36 4.0–5.2
MCV (fL) 81.13 80–92
MCH (pg) 25.84 27–31
RDW-CV (%) 11.88 11.5–14.5
Hb A (%): retention
time/min
35.01: 2.618 94–99
Hb A2 (%): retention
time/min
3.99: 3.141 0–3.90
Unknown peak (%):
retention time/min
57.31: 2.701 –
Serum LDH level (U/L) 257 90–241
Serum iron level (g/dL) 32 40–170
-Globin genotype c.235  C>G/A A/A
Hb: Hemoglobin; RBC: red blood cell count; MCV: mean corpuscular
volume; MCH: mean corpuscular hemoglobin; RDW: red blood cell
distribution width; LDH: lactate dehydrogenase.
Reference ranges used are based on the equipment manufacturers’
established values for the gender and age group of the proband.
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Figure 1 – Pattern of the patient with 78(EF2) Leu>Val;
HBB: c.235 C>G mutation using an in-house
high-performance liquid chromatography (HPLC) system. In
our method, a reference HPLC pattern comprises Hb A1c, Hb
F, Hb A and Hb A2 chains respectively with their order of
appearance on the chromatogram. However, an abnormal
variant peak (indicated with an arrow) was observed in the
proband on the 2.7th minute of the migration through the
column with a concentration of 57.3%. Additionally, Hb A2
level (retention time: 3.141 min) of the proband was slightly
Hb A and Hb A2 on the HPLC chromatogram in the ﬁrst reportreaction (PCR) and the PCR product was analyzed by direct
nucleotide sequencing using a Beckman Coulter CEQ 2000XL
DNA sequencer.
DNA sequencing of the entire beta globin gene and the pro-
moter region revealed the proband was heterozygous for the
78(EF2) Leu>Val; HBB: c.235 C>G mutation, named Hb Ullevaal
as described by Grimholt et al.3 (Figure 2).
This variant has previously been reported in only one per-
son, a 61-year-old female Norway resident from Bosnia, a
community with cultural and economical aspects similar to
Turkey since the Ottoman Empire, suggesting a historical pathPlease cite this article in press as: Hocaoglu-Emre FS, et al. First observa
Hemoter. 2016. http://dx.doi.org/10.1016/j.bjhh.2016.09.013
for the mutation. Although no abnormal pattern was observed
by HPLC analysis and the mutation was detected incidentally
when the patient was referred for the measurement of Hb A1c
Figure 2 – Sequence analysis of the case identiﬁed in the study s
Leu>Val; HBB: c.235 C>G).increased (3.99% compared to the reference range of
0–3.90%).
by cation exchange HPLC, the variant Hb peak resided betweention of Hb Ullevaal [78(EF2) Leu>Val] in Turkey. Rev Bras Hematol
deﬁning this substitution. Additionally, moderate anemia with
decreased RBC, Hb, MCV,  MCH and iron levels and a slightly
elevated LDH concentration was present in the proband.
howing the heterozygosity for Hb Ullevaal (78(EF2)
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Unfortunately, we were not able to analyze other family
embers genetically. However, sequence analysis involving
he alpha globin gene and beta-globin gene promoter region
esulted in no variations.
As Leucine and Valine are both basic amino acids and
his substitution does not change the net charge of the
eta-globin molecule, a computerized analysis using the Gar-
ier Osguthorpe Robson (GOR) method for protein structure
rediction software revealed an altered beta helix structure.
he loop angle corresponding to the substituted amino acid
egion was narrower assuming a conformational change in
he protein.
The beta globin gene cluster haplotypes of this mutation
re linked to haplotype 1 (+ − − − − + +) in our case.4
In conclusion, as the ﬁrst report of the described mutation
uggests there should be no anemia in the proband, the ane-
ia  seen in this case might be a result of iron deﬁciency or
ther conditions. This very ﬁrst report of the 78(EF2) Leu>Val;
BB: c.235 C>G mutation in a Turkish individual highlightsPlease cite this article in press as: Hocaoglu-Emre FS, et al. First observa
Hemoter. 2016. http://dx.doi.org/10.1016/j.bjhh.2016.09.013
he great diversity of the beta globin gene present in the Turk-
sh population and contributes knowledge of the mutational
elationship in a ‘bench top archeological’ manner between
ifferent communities due to historical connections. 1 6;x x x(x x):xxx–xxx 3
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